Rod Wilson
Nessuna posizione attualmente
Profilo
Rod Wilson is President and Chief Operating Officer of Nanogen, Inc. He joined Nanogen in April 2004.
He was Vice President of Sales for GlaxoSmithKline.
He was Director of Marketing for Eli Lilly Canada, Inc. He was Vice President of Sales and Marketing for Rx Plus.
He received his BBA from the University of New Brunswick.
Precedenti posizioni note di Rod Wilson
| Società | Posizione | Fine |
|---|---|---|
| NGEN INC | Presidente | - |
Formazione di Rod Wilson
| University of New Brunswick | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Società collegate
| Aziende private | 1 |
|---|---|
Ngen, Inc.
 Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
- Borsa valori
- Insiders
- Rod Wilson
